Acrolein toxicity at advanced age: present and future
Sign Up to like & getrecommendations! Published in 2017 at "Amino Acids"
DOI: 10.1007/s00726-017-2527-x
Abstract: It is thought that tissue damage at advanced age is mainly caused by ROS (reactive oxygen species, O2−, H2O2, and ·OH). However, it was found that acrolein (CH2=CH–CHO) is more toxic than ROS, and is… read more here.
Keywords: acrolein toxicity; age present; age; advanced age ... See more keywords
Pemetrexed exposure predicts toxicity in advanced non-small-cell lung cancer: A prospective cohort study.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of cancer"
DOI: 10.1016/j.ejca.2019.08.012
Abstract: BACKGROUND We explored whether total exposure to pemetrexed predicts effectiveness and toxicity in advanced non-small-cell lung cancer (NSCLC). Furthermore, we investigated alternative dosing schedules. METHODS In this prospective cohort study, patients with advanced NSCLC receiving… read more here.
Keywords: advanced non; exposure; toxicity; non small ... See more keywords
Toxicity of advanced glycation end products (Review)
Sign Up to like & getrecommendations! Published in 2021 at "Biomedical Reports"
DOI: 10.3892/br.2021.1422
Abstract: Advanced glycation end-products (AGEs) are proteins or lipids glycated nonenzymatically by glucose, or other reducing sugars and their derivatives, such as glyceraldehyde, glycolaldehyde, methyloglyoxal and acetaldehyde. There are three different means of AGE formation: i)… read more here.
Keywords: end products; glycation end; products review; advanced glycation ... See more keywords